Rank | Ticker | Company | Weight | Country | Market Cap | Industry |
---|---|---|---|---|---|---|
1 | IMGN | ImmunoGen Inc | 5.52% | United States | $976.52m | Biotechnology |
2 | VKTX | Viking Therapeutics Inc | 4.54% | United States | $1.54b | Biotechnology |
3 | AGEN | Agenus Inc | 2.09% | United States | $457.22m | Biotechnology |
4 | BPMC | Blueprint Medicines Corp | 1.93% | United States | $2.92b | Biotechnology |
5 | TWST | Twist Bioscience Corp | 1.71% | United States | $701.27m | Diagnostics & Research |
6 | IOVA | Iovance Biotherapeutics Inc | 1.66% | United States | $1.20b | Biotechnology |
7 | CYTK | Cytokinetics Inc | 1.65% | United States | $3.60b | Biotechnology |
8 | ISEE | IVERIC bio Inc | 1.63% | United States | $4.43b | Biotechnology |
9 | KRTX | Karuna Therapeutics Inc | 1.62% | United States | $6.63b | Biotechnology |
10 | RXDX | Prometheus Biosciences Inc | 1.54% | United States | $9.22b | Biotechnology |
11 | RVMD | Revolution Medicines Inc | 1.51% | United States | $2.43b | Biotechnology |
12 | NTRA | Natera Inc | 1.49% | United States | $5.69b | Diagnostics & Research |
13 | PCVX | Vaxcyte Inc | 1.4% | United States | $3.38b | Biotechnology |
14 | CTIC | CTi Biopharma Corp | 1.33% | United States | $631.49m | Biotechnology |
15 | MRTX | Mirati Ther | 1.32% | United States | $2.53b | Biotechnology |
16 | RYTM | Rhythm Pharmaceuticals Inc | 1.31% | United States | $1.13b | Biotechnology |
17 | ARDX | Ardelyx Inc | 1.29% | United States | $933.35m | Biotechnology |
18 | NBIX | Neurocrine Biosciences Inc | 1.28% | United States | $9.84b | Drug Manufacturers-Specialty & Generic |
19 | INSM | Insmed Inc | 1.26% | United States | $2.63b | Biotechnology |
19 | KRYS | Krystal Biotech Inc | 1.26% | United States | $2.16b | Biotechnology |
21 | EXEL | Exelixis Inc | 1.25% | United States | $5.89b | Biotechnology |
22 | VRTX | Vertex Pharmaceuticals Inc | 1.23% | United States | $87b | Biotechnology |
22 | SWTX | SpringWorks Therapeutics Inc | 1.23% | United States | $1.45b | Biotechnology |
24 | IMVT | Immunovant Inc | 1.22% | United States | $2.09b | Biotechnology |
25 | SGEN | Seagen Inc | 1.16% | United States | $38b | Biotechnology |
26 | CERE | Cerevel Therapeutics Holdings Inc | 1.14% | United States | $4.44b | Biotechnology |
27 | CRSP | Crispr Therapeutics AG | 1.13% | United States | $3.86b | Biotechnology |
28 | IONS | Ionis Pharmaceuticals Inc | 1.1% | United States | $5.04b | Biotechnology |
29 | AMGN | Amgen Inc | 1.06% | United States | $128b | Drug Manufacturers-General |
29 | REGN | Regeneron Pharmaceuticals Inc | 1.06% | United States | $85b | Biotechnology |
31 | RARE | Ultragenyx | 1% | United States | $2.98b | Biotechnology |
31 | RNA | Avidity Biosciences Inc | 1% | United States | $1.03b | Biotechnology |
33 | ABBV | AbbVie Inc | 0.98% | United States | $263b | Drug Manufacturers-General |
34 | ACLX | Arcellx Inc | 0.97% | United States | $1.96b | Biotechnology |
35 | KYMR | Kymera Therapeutics Inc | 0.95% | United States | $1.73b | Biotechnology |
36 | HZNP | Horizon Pharma PLC | 0.92% | United States | $25b | Drug Manufacturers-General |
37 | UTHR | United Therapeutics Corporation | 0.91% | United States | $10.54b | Biotechnology |
37 | CPRX | Catalyst Pharmaceuticals Inc | 0.91% | United States | $1.64b | Biotechnology |
39 | EXAS | EXACT Sciences Corporation | 0.9% | United States | $11.31b | Diagnostics & Research |
40 | BMRN | Biomarin Pharmaceutical Inc | 0.89% | United States | $17.24b | Biotechnology |
41 | BBIO | BridgeBio Pharma Inc | 0.87% | United States | $2.27b | Biotechnology |
41 | TGTX | TG Therapeutics Inc | 0.87% | United States | $3.41b | Biotechnology |
43 | GERN | Geron Corporation | 0.85% | United States | $1.07b | Biotechnology |
44 | AGIO | Agios Pharm | 0.84% | United States | $1.23b | Biotechnology |
45 | HALO | Halozyme Therapeutics Inc | 0.83% | United States | $4.36b | Biotechnology |
46 | ADMA | ADMA Biologics Inc | 0.82% | United States | $731.19m | Biotechnology |
46 | RCUS | Arcus Biosciences Inc | 0.82% | United States | $1.28b | Biotechnology |
48 | FOLD | Amicus Therapeutics Inc | 0.81% | United States | $3.22b | Biotechnology |
48 | ALKS | Alkermes Plc | 0.81% | United States | $4.66b | Drug Manufacturers-Specialty & Generic |
50 | DVAX | Dynavax Technologies Corporation | 0.8% | United States | $1.33b | Drug Manufacturers-Specialty & Generic |